While we may not recognize it, we all use the skills
necessary to conduct and interpret “ clinical trials ” every
single day. Sampling and comparing one restaurant, article
of clothing, television show, fi tness club,
...
While we may not recognize it, we all use the skills
necessary to conduct and interpret “ clinical trials ” every
single day. Sampling and comparing one restaurant, article
of clothing, television show, fi tness club, vacation location, date, job candidate, or client to another is effectively
conducting a clinical trial. Evidence and results from these
mini-trials guide your choices and decisions throughout
the day. Should you buy that swimsuit? Is it better than the
one in the other store? Are the Philadelphia Eagles or the
Pittsburgh Steelers a better football team? Which sushi
restaurant has the best salmon? What job will provide the
best experience? Where should you live and what house
should you buy? Is it better to hire Job Candidate #1 or Job
Candidate #2? Faulty “ trial ” design, data, or interpretation
leads to inaccurate assessments and perhaps poor decisions.
For example, using the wrong criteria will result in hiring
the wrong person for a job. We all have suffered from that
impulse buy, that forehead-slapping wrong decision, or that
bad choice of friend, employee, or signifi cant other.
Formal and informal clinical trials are a large part of our
lives. If you use, produce, study, purchase, invest in, or conduct research in drugs, medical devices, or any type of health
care intervention, understanding the science and operations of
formal clinical trials can only help. Today, even understanding many major news items requires at least some knowledge of clinical trials. Whenever a drug or medical device is
recalled, a medical intervention is debunked, or a new therapy hits the market, clinical trial design, conduct, or analysis is at the heart of the evidence or the controversy. Health
care is such a major business that even seemingly unrelated
industries and professions can be dramatically affected by a
successful or unsuccessful clinical trial. Flaws in a clinical
trial that force a major drug or device to be pulled from the
market can alter many lives and rock the economy.
Therefore, during our planning stages for Principles and
Practices of Clinical Trial Medicine , confi ning the book ’ s
audience was diffi cult. Should this book be geared toward just
physicians? Pharmaceutical industry professionals? Statisticians? Academics? Clinical research specialists? Regulatory
professionals? Ethicists? Medical students? Nursing students? Medicine residents? Graduate students? Post-doctoral
fellows? Epidemiologists? Engineers? Pharmacologists?
Pharmacists? Biologists? Pharmaceutical or medical device
executives? The more we thought about it, the more we
realized that the audience could be quite broad. Both of our
career journeys have taken us through a variety of functions and domains in industry, academics, and business. We
have seen the investment, research, technical, management,
teaching, writing, consulting, and clinical practice realms
of the health care industry. In the end, while each area may
have different jargon, cultures, personalities, and perspectives, the guiding principles are the same. A good clinical
trial at an academic institution is a good one in industry and
vice-versa.
Therefore, we wrote this book with a broad audience in
mind, trying to minimize the jargon and explain any important terminology in the process. The goal was to write a
book that could be easily understood regardless of your
background, especially since people from so many different backgrounds are involved in clinical trials. In fact, in
many professions, understanding the jargon and terminology is half the battle.
Moreover, regardless of your interest and function in
the clinical research world, knowing the general concepts
of all aspects of clinical trials can be very advantageous.
In many ways, the clinical research world has become far
too specialized. Many individuals stay ensconced within
their areas of knowledge and expertise. But the best clinical researchers or trialists have broad knowledge bases that
span statistics, regulatory affairs, ethics, clinical medicine,
science, basic probability, data management, and trial and
personnel management. The ones that stand out, are most
marketable, and do the best work cannot afford to say, “ I
do not need to know that because it is not in my area. ”
xii Introduction
Designing, conducting, and analyzing a clinical trial is
like designing, building, and using a house. Recognizing
a house ’ s design and construction helps you realize its
potential use. For example, a thin-walled house may cause
problems during the winter. Very cramped rooms may not
facilitate hosting a party. At the same time, anticipating the
house ’ s use aids its design and construction. Your design
of a beach house likely will differ signifi cantly from your
design of a farm house or a city dwelling.
The “ building a house ” analogy helps illustrate the general organization of our book. The Principles and Practices
of Clinical Trial Medicine contains fi ve sections. Section I
introduces the fi eld of clinical research with Chapter 1 delineating some general theory and Chapter 2 covering important legal, ethical, and regulatory issues. The materials
in this section are analogous to all of the rules and regulations that govern the construction of a house: ranging from
general engineering and architectural principles to zoning
laws and building codes. Just as you can ’ t build any kind of
house anywhere you choose (e.g., Igloos do not belong in
Philadelphia or San Francisco), you must understand general
clinical research theory and comply with legal, ethical, and
regulatory principles when designing and conducting a trial.
Section II focuses on the general design of clinical trials. If
you imagine a clinical trial to be a house, statistics (Chapter 3)
are the tools used to build the house. The fi nal design of the
house depends heavily on the tools that you have at your disposal. Sure you can rely on others to choose and wield the
tools… but would you truly know and trust the house? To be
truly competent at clinical research, you have to know your
tools, even if you have specialists to employ them. Measures
and Variables (Chapter 4) are the construction materials for
the house. Construction materials help determine the house ’ s
appearance and utility. Building a house resistant to harsh elements may be diffi cult without good quality bricks or cinder
blocks. Similarly, studying heart disease may be challenging
without accurate echocardiograms, electrocardiograms, and
blood pressure measurements. Study Groups (Chapter 5) and
Periods, Sequences and Design (Chapter 6) are the rooms
and corridors of the house. Changing these will dramatically
change the house ’ s functionality and purpose. Having no
kitchen makes cooking and hosting dinner parties diffi cult.
An indoor garage allows you to shield your car from the elements. Similarly, comparing two medical interventions normally requires employing at least two different study groups.
Seeing the long-term effects of a drug necessitates patients
being on the drug for a long period of time.
Section III takes a closer look at an array of important elements in clinical trial design. Endpoints (Chapter 7) are special
measures and variables that serve as the outcomes of the trial.
So, continuing our building analogy, endpoints are the key
construction materials that determine the worth, strength, and
use of the house. Chapter 8 (Economics and Patient Reported
Outcomes) discusses some special types of endpoints,
Chapter 9 (Patient Selection and Sampling) reviews considerations when choosing patients for your trial, and Chapter 10
(Dosing and Intervention) analyzes how medical interventions
should be administered to patients. All of these are as important factors and parameters to clinical trials as ceiling height,
room size, lighting, house temperature, and other features are
to house construction. Chapter 11 Epidemiology, Decision
analysis and simulation offers additional tools that may help
in the planning and analysis of trials, and is analogous to the
model building and “ roughing-in ” phase of house building,
where you visualize how a house might look.
Section IV covers practical logistical issues involved in
conducting a trial. This is analogous to concerns that arise
when actually building the house. For example, from where
do you procure building materials? Which forms should you
complete when ordering such materials? Which nails should
you use? Where should you place the beams? How do you
select and supervise the contractor? All of these types
of issues are discussed in Chapter 12 Study Execution.
Recruiting Patients and Choosing Trial Locations (Chapter
13) are such an important part of conducting trials that a
separate chapter is devoted to the topic.
Finally, Section V discusses how to analyze the results
of clinical trial. In our building analogy, this is similar
to using and inhabiting the house. Data is the output of a
clinical trial, just as a house is the end product of house
construction. Chapter 14, Assessing Data Quality and Transforming Data, is akin to inspecting the house and making
the fi nal adjustments and reworking anything that needs to
be reworked. If the stairs are not to code, they need to be
redone, and if the painters overpainted the moldings, they
need to be repainted. Data similarly need to the cleaned and
transformed, to ameliorate missing or unreliable data points.
Chapter 15, Analysis of Data, is akin to decorating the
house and moving the furniture into the appropriate rooms.
You manipulate the data that has been gathered and prepared.
This allows you to then interpret the data, which is the subject
of Chapter 16 Data interpretation and conclusions. This is
akin to moving into the house and living in it. This is the acid
test. No matter how well-built or well-decorated the house
is, if you don ’ t enjoy living in it, all has been for naught.
Similarly, the ultimate end product of a clinical trial is a conclusion that is actionable for the treatment of future patients.
So whether you are new to the world of clinical trials or
have been conducting clinical research for many years, we
hope that this book serves you well. The importance and
use of clinical trials will only continue to grow in the future.
Concomitantly, trial design and conduct will face increasing
scrutiny. In many cases, lives of innumerable patients and
signifi cant amount of time and resources will be riding on
them. Will you be ready?
[Show More]